MOnaliZumab in Combination With durvAlumab (MEDI4736) Plus Platinum-based chemotheRapy for First-line Treatment of Extensive Stage Small Cell Lung Cancer

Conditions:   Small Cell Lung Cancer;   SCLC;   Extensive Stage Small Cell Lung Cancer Interventions:   Drug: Durvalumab;   Drug: Monalizumab;   Drug: Carboplatin or Cisplatin;   Drug: Etoposide Sponsors:   Hirva Mamdani;   AstraZeneca;   Barbara Ann Karmanos Cancer Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials